Hypersensitivity reactions to carboplatin and paclitaxel - our five-years experiences

Abstract

Objective: To analyze hypersensitivity reactions to carboplatin and paclitaxel in patients treated with systemic administration of chemotherapy (carboplatin and/or paclitaxel). Conclusion: HSR to carboplatin is unlike paclitaxel affected by the number of administered cycles.

This fact should be included in the clinical management of patients treated with intravenous chemotherapy using carboplatin.

Keywords

• chemotherapy
• allergic reaction
• ovarian cancer